Literature DB >> 18322542

Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

S-K Jo1, A Bajwa, A S Awad, K R Lynch, M D Okusa.   

Abstract

The major sphingolipid metabolite, sphingosine-1-phosphate (S1P), has important biological functions. S1P is the ligand for a family of five G-protein-coupled receptors with distinct signaling pathways that regulate angiogenesis, vascular maturation, immunity, chemotaxis, and other important biological pathways. Recently, clinical trials have targeted S1P receptors (S1PRs) for autoimmune diseases and transplantation and have generated considerable interest in developing additional, more selective compounds. This review summarizes current knowledge on the biology of S1P and S1PRs that forms the basis for future drug development and the treatment of kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322542      PMCID: PMC2614447          DOI: 10.1038/ki.2008.34

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  159 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors.

Authors:  Michael J Kluk; Timothy Hla
Journal:  Biochim Biophys Acta       Date:  2002-05-23

3.  Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells.

Authors:  Vera Krump-Konvalinkova; Satoshi Yasuda; Tina Rubic; Natalia Makarova; Jörg Mages; Wolfgang Erl; Claudia Vosseler; C James Kirkpatrick; Gabor Tigyi; Wolfgang Siess
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-23       Impact factor: 8.311

Review 4.  Tipping the gatekeeper: S1P regulation of endothelial barrier function.

Authors:  Hugh Rosen; M Germana Sanna; Stuart M Cahalan; Pedro J Gonzalez-Cabrera
Journal:  Trends Immunol       Date:  2007-02-05       Impact factor: 16.687

5.  Sphingosine 1-phosphate analogs as receptor antagonists.

Authors:  Michael D Davis; Jeremy J Clemens; Timothy L Macdonald; Kevin R Lynch
Journal:  J Biol Chem       Date:  2004-12-08       Impact factor: 5.157

6.  Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury.

Authors:  J Deng; Y Kohda; H Chiao; Y Wang; X Hu; S M Hewitt; T Miyaji; P McLeroy; B Nibhanupudy; S Li; R A Star
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

7.  Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.

Authors:  Angela M Whetzel; David T Bolick; Suseela Srinivasan; Timothy L Macdonald; Margaret A Morris; Klaus Ley; Catherine C Hedrick
Journal:  Circ Res       Date:  2006-09-07       Impact factor: 17.367

8.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

Review 9.  Thrombogenic and atherogenic activities of lysophosphatidic acid.

Authors:  Wolfgang Siess; Gabor Tigyi
Journal:  J Cell Biochem       Date:  2004-08-15       Impact factor: 4.429

10.  Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals.

Authors:  R Bose; M Verheij; A Haimovitz-Friedman; K Scotto; Z Fuks; R Kolesnick
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

View more
  43 in total

1.  Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus.

Authors:  L Watson; K Tullus; S D Marks; R C L Holt; C Pilkington; M W Beresford
Journal:  J Clin Immunol       Date:  2012-05-31       Impact factor: 8.317

Review 2.  Drug discovery in focal and segmental glomerulosclerosis.

Authors:  Nick Pullen; Alessia Fornoni
Journal:  Kidney Int       Date:  2016-04-23       Impact factor: 10.612

Review 3.  Macrophages, dendritic cells, and kidney ischemia-reperfusion injury.

Authors:  Li Li; Mark D Okusa
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

Review 4.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

5.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

Review 6.  Targeting sphingosine-1-phosphate receptors in cancer.

Authors:  Rebecca J Watters; Hong-Gang Wang; Shen-Shu Sung; Thomas P Loughran; Xin Liu
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

7.  Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Joseph C Gigliotti; Hong Ye; Jacqueline Miller; Diane L Rosin; Peter I Lobo; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 10.121

8.  Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.

Authors:  Zhengrong Guan; Sean T Singletary; Anthony K Cook; Janet L Hobbs; Jennifer S Pollock; Edward W Inscho
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

Review 9.  Immune mechanisms and novel pharmacological therapies of acute kidney injury.

Authors:  Amandeep Bajwa; Gilbert R Kinsey; Mark D Okusa
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

10.  Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Gαq-mediated Rho and αvβ6 integrin-dependent activation of TGF-β.

Authors:  Hui Geng; Rongpei Lan; Prajjal K Singha; Annette Gilchrist; Paul H Weinreb; Shelia M Violette; Joel M Weinberg; Pothana Saikumar; Manjeri A Venkatachalam
Journal:  Am J Pathol       Date:  2012-08-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.